A Phase II Trial of Erlotinib in Combination With Bevacizumab in Patients With Metastatic Breast Cancer
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-08-0141
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2008
Authors
Publisher
American Association for Cancer Research (AACR)